Stock Performance and Market Context
On 20 Apr 2026, Integrated Proteins Ltd opened and traded steadily at Rs.91.62, marking its highest-ever price level. The stock outperformed its sector by 2.24% on the day and recorded a daily gain of 1.99%, significantly surpassing the Sensex’s 0.38% rise. Over the past week, the stock appreciated by 8.22%, while the Sensex gained 2.53%. The momentum accelerated over the month, with the stock climbing 47.04% compared to the Sensex’s 5.71% increase.
More impressively, the three-month performance of Integrated Proteins Ltd stands at a staggering 186.40%, contrasting sharply with the Sensex’s decline of 4.12% during the same period. Year-to-date, the stock has surged 166.34%, while the benchmark index has fallen 7.54%. Over a longer horizon, the stock’s 10-year return of 4181.31% dwarfs the Sensex’s 204.87%, highlighting its exceptional growth trajectory.
Technical Indicators and Trend Analysis
The technical outlook for Integrated Proteins Ltd is decidedly bullish. The stock has been on a consistent upward trend since 27 Mar 2026, when it crossed the Rs.71.33 mark, transitioning from a sideways movement to a strong uptrend. It currently trades above all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling robust momentum.
Key technical indicators reinforce this positive stance. The MACD and Bollinger Bands show bullish signals on both weekly and monthly charts, while the Dow Theory also supports the upward trend. The Relative Strength Index (RSI) presents a bearish signal on the weekly scale but shows no signal monthly, suggesting some short-term caution amid the broader positive trend. The KST indicator is bullish weekly but mildly bearish monthly, indicating mixed momentum in different time frames.
Immediate support is anchored at the 52-week low of Rs.20.71, while resistance levels previously noted at Rs.74.19 (20-day moving average) and Rs.57.75 (52-week high) have been decisively surpassed, with the stock now trading well above these benchmarks.
Valuation Metrics Reflect Elevated Market Expectations
Integrated Proteins Ltd’s valuation multiples as of 20 Apr 2026 reflect elevated market expectations. The price-to-earnings (P/E) ratio stands at a high 509 times trailing twelve months earnings, while the price-to-book value (P/BV) ratio is 8.26 times. Enterprise value multiples such as EV/EBITDA and EV/EBIT are both at 168.10 times, and EV/Sales is 6.54 times. These figures indicate that investors are pricing in significant growth potential, despite the company’s current earnings profile.
Dividend metrics are not applicable, with no dividend yield or payout reported. The absence of dividend distribution aligns with the company’s reinvestment strategy and growth focus.
Quality and Financial Trends
Integrated Proteins Ltd’s quality assessment categorises it as a below-average quality company based on long-term financial performance. The management risk and capital structure are rated below average, while growth is considered average. The company has demonstrated a strong sales growth rate of 92.87% over five years, though EBIT growth has been modest at 7.26% during the same period.
Financial leverage remains low, with negligible debt levels and no promoter share pledging. The average return on capital employed (ROCE) and return on equity (ROE) are weak at -5.14% and 1.51% respectively, reflecting challenges in translating sales growth into profitability. The average EBIT to interest coverage ratio is negative, indicating limited earnings buffer against interest expenses.
Delivery Volumes and Market Activity
Recent delivery volumes show a notable increase, with a 1-day delivery change of 79.75% compared to the 5-day average, and a 1-month delivery change of 4.77%. This suggests heightened trading activity and investor participation in the stock during its rally phase.
Historical Price Range and Returns
The stock’s 52-week range has expanded significantly, with the low at Rs.20.71 and the previous high at Rs.57.75. The current price of Rs.91.62 represents a 58.65% premium over the previous 52-week high and a remarkable 342.39% increase from the low. Over three years, the stock has delivered a return of 696.70%, vastly outperforming the Sensex’s 32.13% gain in the same period.
Summary of Market Capitalisation and Ratings
Integrated Proteins Ltd is classified as a micro-cap company within the edible oil sector. The MarketsMOJO Mojo Score stands at 44.0, with a current Mojo Grade of Sell, upgraded from a previous Strong Sell rating on 27 Mar 2026. This upgrade coincides with the stock’s shift to a bullish trend and its recent price appreciation.
Conclusion
The attainment of an all-time high price of Rs.91.62 by Integrated Proteins Ltd marks a significant milestone in the company’s market journey. Supported by a sustained bullish trend, strong relative performance against benchmarks, and increased trading volumes, the stock’s rally reflects a period of robust market confidence. While valuation multiples remain elevated and quality metrics indicate areas for improvement, the stock’s price action over recent months highlights a noteworthy phase of growth and market recognition within the edible oil sector.
